These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18922422)

  • 21. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
    Yilmaz D; Karapinar B; Balkan C; Akisü M; Kavakli K
    Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Failure of recombinant factor VIIa to correct the coagulopathy in a case of severe postpartum hemorrhage.
    Lewis NR; Brunker P; Lemire SJ; Kaufman RM
    Transfusion; 2009 Apr; 49(4):689-95. PubMed ID: 19347977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recombinant activated factor VII (NovoSeven): addition to replacement therapy in acute, uncontrolled and life-threatening bleeding.
    Mayo A; Misgav M; Kluger Y; Geenberg R; Pauzner D; Klausner J; Ben-Tal O
    Vox Sang; 2004 Jul; 87(1):34-40. PubMed ID: 15260820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibrinogen and FXIII dose response effects on albumin-induced coagulopathy.
    Hanna J; Winstedt D; Schött U
    Scand J Clin Lab Invest; 2013 Oct; 73(7):553-62. PubMed ID: 24004348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The in vitro effects of fibrinogen concentrate, factor XIII and fresh frozen plasma on impaired clot formation after 60% dilution.
    Haas T; Fries D; Velik-Salchner C; Reif C; Klingler A; Innerhofer P
    Anesth Analg; 2008 May; 106(5):1360-5, table of contents. PubMed ID: 18420845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibrinogen concentrate reverses dilutional coagulopathy induced in vitro by saline but not by hydroxyethyl starch 6%.
    De Lorenzo C; Calatzis A; Welsch U; Heindl B
    Anesth Analg; 2006 Apr; 102(4):1194-200. PubMed ID: 16551923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII.
    Moscardó F; Pérez F; de la Rubia J; Balerdi B; Lorenzo JI; Senent ML; Aznar I; Carceller S; Sanz MA
    Br J Haematol; 2001 Jul; 114(1):174-6. PubMed ID: 11472364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time for changing coagulation management in trauma-related massive bleeding.
    Fries D; Innerhofer P; Schobersberger W
    Curr Opin Anaesthesiol; 2009 Apr; 22(2):267-74. PubMed ID: 19390253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The in-vitro effect of fibrinogen, factor XIII and thrombin-activatable fibrinolysis inhibitor on clot formation and susceptibility to tissue plasminogen activator-induced fibrinolysis in hemodilution model.
    Shenkman B; Livnat T; Lubetsky A; Tamarin I; Budnik I; Einav Y; Martinowitz U
    Blood Coagul Fibrinolysis; 2012 Jul; 23(5):370-8. PubMed ID: 22498982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential role of recombinant factor VIIa as a hemostatic agent.
    Hedner U; Erhardtsen E
    Clin Adv Hematol Oncol; 2003 Feb; 1(2):112-9. PubMed ID: 16224390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged prothrombin time after recombinant activated factor VII therapy in critically bleeding trauma patients is associated with adverse outcomes.
    McMullin NR; Wade CE; Holcomb JB; Nielsen TG; Rossaint R; Riou B; Rizoli SB; Kluger Y; Choong PI; Warren B; Tortella BJ; Boffard KD;
    J Trauma; 2010 Jul; 69(1):60-9. PubMed ID: 20622579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.
    Dunkley S; Phillips L; McCall P; Brereton J; Lindeman R; Jankelowitz G; Cameron P
    Ann Thorac Surg; 2008 Mar; 85(3):836-44. PubMed ID: 18291152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant activated factor VII: treating postoperative hemorrhage in cardiac surgery.
    Bishop CV; Renwick WE; Hogan C; Haeusler M; Tuckfield A; Tatoulis J
    Ann Thorac Surg; 2006 Mar; 81(3):875-9. PubMed ID: 16488687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Administration off label of recombinant factor-VIIa (rFVIIa) to patients with blunt or penetrating brain injury without coagulopathy.
    Zaaroor M; Soustiel JF; Brenner B; Bar-Lavie Y; Martinowitz U; Levi L
    Acta Neurochir (Wien); 2008 Jul; 150(7):663-8. PubMed ID: 18473114
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy.
    Shami VM; Caldwell SH; Hespenheide EE; Arseneau KO; Bickston SJ; Macik BG
    Liver Transpl; 2003 Feb; 9(2):138-43. PubMed ID: 12548507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrinogen in craniosynostosis surgery.
    Haas T; Fries D; Velik-Salchner C; Oswald E; Innerhofer P
    Anesth Analg; 2008 Mar; 106(3):725-31, table of contents. PubMed ID: 18292409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postpartum hemorrhage: when uterotonics and sutures fail.
    James AH; McLintock C; Lockhart E
    Am J Hematol; 2012 May; 87 Suppl 1():S16-22. PubMed ID: 22430921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An in vitro evaluation of standard rotational thromboelastography in monitoring of effects of recombinant factor VIIa on coagulopathy induced by hydroxy ethyl starch.
    Engström M; Reinstrup P; Schött U
    BMC Blood Disord; 2005 Feb; 5(1):3. PubMed ID: 15713229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet-dependent thrombin generation assay for monitoring the efficacy of recombinant Factor VIIa.
    Wegert W; Harder S; Bassus S; Kirchmaier CM
    Platelets; 2005 Feb; 16(1):45-50. PubMed ID: 15763896
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coagulation Management During Liver Transplantation: Use of Fibrinogen Concentrate, Recombinant Activated Factor VII, Prothrombin Complex Concentrate, and Antifibrinolytics.
    Chow JH; Lee K; Abuelkasem E; Udekwu OR; Tanaka KA
    Semin Cardiothorac Vasc Anesth; 2018 Jun; 22(2):164-173. PubMed ID: 29099345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.